A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the
treatment of participants with mild to moderate diabetic kidney disease.